AllianceBernstein’s Icosavax, Inc. Common Stock ICVX Stock Holding History

AllianceBernstein’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27,270	Closed	-$430K	–	3208
2023 Q4	$430K	Buy	27,270 +1,880	+7%	+$18.1K	﹤0.01%	2680
2023 Q3	$197K	Buy	25,390 +3,240	+15%	+$26.9K	﹤0.01%	2969
2023 Q2	$220K	Buy	22,150 +11,350	+105%	+$90.9K	﹤0.01%	2955
2023 Q1	$62.6K	Buy	+10,800	New	+$93.3K	﹤0.01%	3077

AllianceBernstein's ICVX Position: Q1 2024 in Review

AllianceBernstein sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 27,270 shares — an estimated $430K sold.

AllianceBernstein first reported a position in ICVX in Q1 2023 and held it in 4 quarters. The position peaked at $430K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

AllianceBernstein reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AllianceBernstein sold 27,270 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $430K.
AllianceBernstein first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
AllianceBernstein's Icosavax, Inc. Common Stock position peaked at $430K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.